STRATA Skin Sciences, Inc. (SSKN)

STRATA Skin Sciences Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-11.36	-10.83	-5.55	-2.71	-4.39	-3.6
Depreciation & Amortization	5.74	5.9	5.69	4.09	3.91	4.82
Share-Based Compensation	1.09	1.3	1.47	1.64	1.63	1.2
Other Operating Activities	4.41	3.11	-2.53	-1.52	0.95	-0.19
Operating Cash Flow	-0.12	-0.52	-0.92	1.51	2.1	2.23
Operating Cash Flow Growth	-	-	-	-28.05%	-5.97%	-23.03%
Capital Expenditures	-4.34	-5.02	-3.74	-3.65	-2.16	-2.79
Acquisitions	0	0	-0.63	-3.47	0	0
Investing Cash Flow	-4.34	-5.02	-4.37	-7.13	-2.16	-2.79
Share Issuance / Repurchase	0	0	0	0	0.02	0
Debt Issued / Paid	-0.06	6.9	0	0.09	2.53	-0.3
Other Financing Activities	-0.06	-0.04	-0.5	-	-	-
Financing Cash Flow	-0.12	6.86	-0.5	0.09	2.55	-0.3
Net Cash Flow	2.39	1.32	-5.79	-5.53	2.48	-0.86
Free Cash Flow	-4.46	-5.54	-4.66	-2.15	-0.06	-0.56
Free Cash Flow Margin	-13.70%	-16.60%	-12.89%	-7.16%	-0.27%	-1.78%
Free Cash Flow Per Share	-1.27	-1.59	-1.34	-0.63	-0.02	-0.18

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).